Synapse Open Synapse
Biology

Grail multicancer detection test wins FDA advisers’ backing

BioPharma Dive · · 2 min read

Panel members said the first-of-a-kind blood test should not be used to replace medical guideline-recommended cancer screenings, however.

Latest from BioPharma Dive